0.017640 0.000000 0.000000 0.000000 0.015870 0.000000 0.000000 0.000000 0.017062 0.000000 0.000000 0.000000 Zhang, X. Schwartz, J.D. Almo, S.C. Nathenson, S.G. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 8 90.00 90.00 90.00 56.690 63.010 58.610 C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking US Proc.Natl.Acad.Sci.USA PNASA6 0040 0027-8424 100 2586 2591 10.1073/pnas.252771499 12606712 Crystal Structure of the Receptor-Binding Domain of Human B7-2: Insights into Organization and Signaling 2003 US Protein Expr.Purif. PEXPEJ 0757 1046-5928 25 105 113 10.1006/prep.2002.1616 Expression, Refolding, Purification, Molecular Characterization, Crystallization, and Preliminary X-ray Analysis of the Receptor Binding Domain of Human B7-2 2002 100 1 CCD 1999-01-01 ADSC QUANTUM 4 MAD M x-ray 1 0.96110 1.0 0.98000 1.0 0.98019 1.0 X9B NSLS 0.96110, 0.98000, 0.98019 SYNCHROTRON NSLS BEAMLINE X9B 12849.631 T lymphocyte activation antigen CD86 Ig V-type domain 2 man polymer B7-2, Activation B7-2 antigen, CTLA-4 counter-receptor B7.2, B70, FUN-1, BU63 no no MLKIQAYFNETADLPCQFANSQNQSLSELVVFWQDQENLVLNEVYLGKEKFDSVHSKYMGRTSFDSDSWTLRLHNLQIKD KGLYQCIIHHKKPTGMIRIHQMNSELSVLA MLKIQAYFNETADLPCQFANSQNQSLSELVVFWQDQENLVLNEVYLGKEKFDSVHSKYMGRTSFDSDSWTLRLHNLQIKD KGLYQCIIHHKKPTGMIRIHQMNSELSVLA A,B polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n human Homo Escherichia sample B7-2 9606 Homo sapiens 562 Escherichia coli BL21(DE3), B834(DE3) plasmid pET3a 1 2.07 40.18 VAPOR DIFFUSION, HANGING DROP 8.5 PEG4000, NaAC, Tris-HCl, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K 277 repository Initial release Version format compliance Version format compliance 1 0 2003-03-11 1 1 2008-04-28 1 2 2011-07-13 the complex between the receptor-binding domain of human B7-2 and dimeric CTLA-4 RCSB Y RCSB 2002-12-05 REL REL MET 0 n 1 MET 0 A LEU 1 n 2 LEU 1 A LYS 2 n 3 LYS 2 A ILE 3 n 4 ILE 3 A GLN 4 n 5 GLN 4 A ALA 5 n 6 ALA 5 A TYR 6 n 7 TYR 6 A PHE 7 n 8 PHE 7 A ASN 8 n 9 ASN 8 A GLU 9 n 10 GLU 9 A THR 10 n 11 THR 10 A ALA 11 n 12 ALA 11 A ASP 12 n 13 ASP 12 A LEU 13 n 14 LEU 13 A PRO 14 n 15 PRO 14 A CYS 15 n 16 CYS 15 A GLN 16 n 17 GLN 16 A PHE 17 n 18 PHE 17 A ALA 18 n 19 ALA 18 A ASN 19 n 20 ASN 19 A SER 20 n 21 SER 20 A GLN 21 n 22 GLN 21 A ASN 22 n 23 ASN 22 A GLN 23 n 24 GLN 23 A SER 24 n 25 SER 24 A LEU 25 n 26 LEU 25 A SER 26 n 27 SER 26 A GLU 27 n 28 GLU 27 A LEU 28 n 29 LEU 28 A VAL 29 n 30 VAL 29 A VAL 30 n 31 VAL 30 A PHE 31 n 32 PHE 31 A TRP 32 n 33 TRP 32 A GLN 33 n 34 GLN 33 A ASP 34 n 35 ASP 34 A GLN 35 n 36 GLN 35 A GLU 36 n 37 GLU 36 A ASN 37 n 38 ASN 37 A LEU 38 n 39 LEU 38 A VAL 39 n 40 VAL 39 A LEU 40 n 41 LEU 40 A ASN 41 n 42 ASN 41 A GLU 42 n 43 GLU 42 A VAL 43 n 44 VAL 43 A TYR 44 n 45 TYR 44 A LEU 45 n 46 LEU 45 A GLY 46 n 47 GLY 46 A LYS 47 n 48 LYS 47 A GLU 48 n 49 GLU 48 A LYS 49 n 50 LYS 49 A PHE 50 n 51 PHE 50 A ASP 51 n 52 ASP 51 A SER 52 n 53 SER 52 A VAL 53 n 54 VAL 53 A HIS 54 n 55 HIS 54 A SER 55 n 56 SER 55 A LYS 56 n 57 LYS 56 A TYR 57 n 58 TYR 57 A MET 58 n 59 MET 58 A GLY 59 n 60 GLY 59 A ARG 60 n 61 ARG 60 A THR 61 n 62 THR 61 A SER 62 n 63 SER 62 A PHE 63 n 64 PHE 63 A ASP 64 n 65 ASP 64 A SER 65 n 66 SER 65 A ASP 66 n 67 ASP 66 A SER 67 n 68 SER 67 A TRP 68 n 69 TRP 68 A THR 69 n 70 THR 69 A LEU 70 n 71 LEU 70 A ARG 71 n 72 ARG 71 A LEU 72 n 73 LEU 72 A HIS 73 n 74 HIS 73 A ASN 74 n 75 ASN 74 A LEU 75 n 76 LEU 75 A GLN 76 n 77 GLN 76 A ILE 77 n 78 ILE 77 A LYS 78 n 79 LYS 78 A ASP 79 n 80 ASP 79 A LYS 80 n 81 LYS 80 A GLY 81 n 82 GLY 81 A LEU 82 n 83 LEU 82 A TYR 83 n 84 TYR 83 A GLN 84 n 85 GLN 84 A CYS 85 n 86 CYS 85 A ILE 86 n 87 ILE 86 A ILE 87 n 88 ILE 87 A HIS 88 n 89 HIS 88 A HIS 89 n 90 HIS 89 A LYS 90 n 91 LYS 90 A LYS 91 n 92 LYS 91 A PRO 92 n 93 PRO 92 A THR 93 n 94 THR 93 A GLY 94 n 95 GLY 94 A MET 95 n 96 MET 95 A ILE 96 n 97 ILE 96 A ARG 97 n 98 ARG 97 A ILE 98 n 99 ILE 98 A HIS 99 n 100 HIS 99 A GLN 100 n 101 GLN 100 A MET 101 n 102 MET 101 A ASN 102 n 103 ASN 102 A SER 103 n 104 SER 103 A GLU 104 n 105 GLU 104 A LEU 105 n 106 LEU 105 A SER 106 n 107 SER 106 A VAL 107 n 108 VAL 107 A LEU 108 n 109 LEU 108 A ALA 109 n 110 ALA 109 A MET 0 n 1 MET 0 B LEU 1 n 2 LEU 1 B LYS 2 n 3 LYS 2 B ILE 3 n 4 ILE 3 B GLN 4 n 5 GLN 4 B ALA 5 n 6 ALA 5 B TYR 6 n 7 TYR 6 B PHE 7 n 8 PHE 7 B ASN 8 n 9 ASN 8 B GLU 9 n 10 GLU 9 B THR 10 n 11 THR 10 B ALA 11 n 12 ALA 11 B ASP 12 n 13 ASP 12 B LEU 13 n 14 LEU 13 B PRO 14 n 15 PRO 14 B CYS 15 n 16 CYS 15 B GLN 16 n 17 GLN 16 B PHE 17 n 18 PHE 17 B ALA 18 n 19 ALA 18 B ASN 19 n 20 ASN 19 B SER 20 n 21 SER 20 B GLN 21 n 22 GLN 21 B ASN 22 n 23 ASN 22 B GLN 23 n 24 GLN 23 B SER 24 n 25 SER 24 B LEU 25 n 26 LEU 25 B SER 26 n 27 SER 26 B GLU 27 n 28 GLU 27 B LEU 28 n 29 LEU 28 B VAL 29 n 30 VAL 29 B VAL 30 n 31 VAL 30 B PHE 31 n 32 PHE 31 B TRP 32 n 33 TRP 32 B GLN 33 n 34 GLN 33 B ASP 34 n 35 ASP 34 B GLN 35 n 36 GLN 35 B GLU 36 n 37 GLU 36 B ASN 37 n 38 ASN 37 B LEU 38 n 39 LEU 38 B VAL 39 n 40 VAL 39 B LEU 40 n 41 LEU 40 B ASN 41 n 42 ASN 41 B GLU 42 n 43 GLU 42 B VAL 43 n 44 VAL 43 B TYR 44 n 45 TYR 44 B LEU 45 n 46 LEU 45 B GLY 46 n 47 GLY 46 B LYS 47 n 48 LYS 47 B GLU 48 n 49 GLU 48 B LYS 49 n 50 LYS 49 B PHE 50 n 51 PHE 50 B ASP 51 n 52 ASP 51 B SER 52 n 53 SER 52 B VAL 53 n 54 VAL 53 B HIS 54 n 55 HIS 54 B SER 55 n 56 SER 55 B LYS 56 n 57 LYS 56 B TYR 57 n 58 TYR 57 B MET 58 n 59 MET 58 B GLY 59 n 60 GLY 59 B ARG 60 n 61 ARG 60 B THR 61 n 62 THR 61 B SER 62 n 63 SER 62 B PHE 63 n 64 PHE 63 B ASP 64 n 65 ASP 64 B SER 65 n 66 SER 65 B ASP 66 n 67 ASP 66 B SER 67 n 68 SER 67 B TRP 68 n 69 TRP 68 B THR 69 n 70 THR 69 B LEU 70 n 71 LEU 70 B ARG 71 n 72 ARG 71 B LEU 72 n 73 LEU 72 B HIS 73 n 74 HIS 73 B ASN 74 n 75 ASN 74 B LEU 75 n 76 LEU 75 B GLN 76 n 77 GLN 76 B ILE 77 n 78 ILE 77 B LYS 78 n 79 LYS 78 B ASP 79 n 80 ASP 79 B LYS 80 n 81 LYS 80 B GLY 81 n 82 GLY 81 B LEU 82 n 83 LEU 82 B TYR 83 n 84 TYR 83 B GLN 84 n 85 GLN 84 B CYS 85 n 86 CYS 85 B ILE 86 n 87 ILE 86 B ILE 87 n 88 ILE 87 B HIS 88 n 89 HIS 88 B HIS 89 n 90 HIS 89 B LYS 90 n 91 LYS 90 B LYS 91 n 92 LYS 91 B PRO 92 n 93 PRO 92 B THR 93 n 94 THR 93 B GLY 94 n 95 GLY 94 B MET 95 n 96 MET 95 B ILE 96 n 97 ILE 96 B ARG 97 n 98 ARG 97 B ILE 98 n 99 ILE 98 B HIS 99 n 100 HIS 99 B GLN 100 n 101 GLN 100 B MET 101 n 102 MET 101 B ASN 102 n 103 ASN 102 B SER 103 n 104 SER 103 B GLU 104 n 105 GLU 104 B LEU 105 n 106 LEU 105 B SER 106 n 107 SER 106 B VAL 107 n 108 VAL 107 B LEU 108 n 109 LEU 108 B ALA 109 n 110 ALA 109 B author_defined_assembly 1 monomeric author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 A N ILE 3 A N ILE 4 A O GLU 104 A O GLU 105 A O ILE 96 A O ILE 97 A N HIS 89 A N HIS 90 A O ILE 86 A O ILE 87 A N PHE 31 A N PHE 32 A N TRP 32 A N TRP 33 A O LEU 40 A O LEU 41 A N TYR 44 A N TYR 45 A O LYS 47 A O LYS 48 A N LEU 13 A N LEU 14 A O LEU 70 A O LEU 71 A O THR 69 A O THR 70 A N ASP 64 A N ASP 65 B N LEU 1 B N LEU 2 B O GLU 104 B O GLU 105 B O MET 101 B O MET 102 B N CYS 85 B N CYS 86 B O ILE 86 B O ILE 87 B N PHE 31 B N PHE 32 B N TRP 32 B N TRP 33 B O LEU 40 B O LEU 41 B N GLU 42 B N GLU 43 B O LYS 49 B O LYS 50 B N LEU 13 B N LEU 14 B O LEU 70 B O LEU 71 B O ARG 71 B O ARG 72 B N SER 62 B N SER 63 1 A GLU 9 -107.59 -152.84 1 A SER 62 -162.35 119.88 1 A THR 93 -59.95 -87.84 1 B GLU 9 -119.28 -145.92 1 B PRO 92 -35.69 -36.83 1 B HIS 99 -176.67 144.30 protein_rep.param protein.top carbohydrate.param carbohydrate.top 49.42 21.94 3.20 9.98 0.00 0.00 -3.55 0.00 -6.43 0.278 0.011 0.214 0.258 0.252 2.70 19.83 629 5842 10.8 95.6 1.00 1.00 RANDOM 1 THROUGHOUT 2 MAD Engh & Huber CNS bulk solvent model used 18.2567 0.37304 isotropic 0.41 0.30 5.00 0.42 0.27 2.70 2.70 19.83 0 1804 0 0 1804 0.008 1.4 26.8 0.63 1.53 1.50 2.55 2.00 2.55 2.00 3.67 2.50 0.236 0.032 0.237 2.80 53 491 599 544 10 8.8 90.8 0.234 0.028 0.236 2.91 70 476 595 546 10 11.8 91.8 0.239 0.028 0.243 3.04 71 486 597 557 10 11.9 93.3 0.219 0.027 0.221 3.20 65 509 597 574 10 10.9 96.0 0.229 0.032 0.23 3.40 52 530 603 582 10 8.6 96.4 0.224 0.027 0.219 3.66 71 517 608 588 10 11.7 96.7 0.218 0.027 0.213 4.03 65 522 604 587 10 10.8 97.2 0.193 0.025 0.185 4.60 58 547 615 605 10 9.4 98.4 0.204 0.027 0.21 5.77 59 559 637 618 10 9.3 97.0 0.2 0.025 0.203 19.83 65 576 664 641 10 9.8 96.5 31.2 2.70 19.83 1NCN 20 0 23 0 21 0 5843 5843 1489970.80 41.080000 0.0 0.0 1 95.5 2.7 2.8 90.8 refinement Axel T. Brunger axel.brunger@yale.edu 1998 Fortran CNS package 1.0 data reduction DENZO data scaling SCALEPACK phasing SOLVE T lymphocyte activation antigen CD86 the receptor-binding domain of human B7-2 1 N N 1 N N A SER 24 A SER 25 HELX_P A SER 26 A SER 27 5 1 3 A GLN 76 A GLN 77 HELX_P A LYS 80 A LYS 81 5 2 5 B SER 24 B SER 25 HELX_P B SER 26 B SER 27 5 3 3 B GLN 76 B GLN 77 HELX_P B LYS 80 B LYS 81 5 4 5 disulf 2.016 A CYS 15 A SG CYS 16 1_555 A CYS 85 A SG CYS 86 1_555 disulf 2.035 B CYS 15 B SG CYS 16 1_555 B CYS 85 B SG CYS 86 1_555 IMMUNE SYSTEM Ig V, beta strands, IMMUNE SYSTEM CD86_HUMAN UNP 1 26 P42081 LKIQAYFNETADLPCQFANSQNQSLSELVVFWQDQENLVLNEVYLGKEKFDSVHSKYMGRTSFDSDSWTLRLHNLQIKDK GLYQCIIHHKKPTGMIRIHQMNSELSVLA 26 134 1NCN 1 109 P42081 A 1 2 110 26 134 1NCN 1 109 P42081 B 1 2 110 1 INITIATING METHIONINE MET 0 1NCN A P42081 UNP 1 2 INITIATING METHIONINE MET 0 1NCN B P42081 UNP 1 6 3 6 3 parallel anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel parallel anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel A LEU 1 A LEU 2 A TYR 6 A TYR 7 A MET 95 A MET 96 A LEU 108 A LEU 109 A GLY 81 A GLY 82 A LYS 90 A LYS 91 A LEU 28 A LEU 29 A ASP 34 A ASP 35 A VAL 39 A VAL 40 A TYR 44 A TYR 45 A LYS 47 A LYS 48 A GLU 48 A GLU 49 A ALA 11 A ALA 12 A PRO 14 A PRO 15 A THR 69 A THR 70 A LEU 72 A LEU 73 A THR 61 A THR 62 A ASP 64 A ASP 65 B LEU 1 B LEU 2 B TYR 6 B TYR 7 B GLY 94 B GLY 95 B LEU 108 B LEU 109 B GLY 81 B GLY 82 B LYS 91 B LYS 92 B LEU 28 B LEU 29 B ASP 34 B ASP 35 B VAL 39 B VAL 40 B TYR 44 B TYR 45 B LYS 47 B LYS 48 B LYS 49 B LYS 50 B ALA 11 B ALA 12 B PRO 14 B PRO 15 B THR 69 B THR 70 B LEU 72 B LEU 73 B THR 61 B THR 62 B ASP 64 B ASP 65 18 P 21 21 2